Common filaggrin gene mutations and risk of cervical cancer

References

• Brown SJ, McLean WH. One remarkable molecule: Filaggrin. J Invest Dermatol 2012;132:751–62.
   PubMed Web of Science ®Google Scholar
• Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441–6.
   PubMed Web of Science ®Google Scholar
• Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006;38:337–42.
   PubMed Web of Science ®Google Scholar
• O’Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008;122:689–93.
   PubMed Web of Science ®Google Scholar
• Rodriguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown SJ, Cordell HJ, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: Robust risk factors in atopic disease. J Allergy Clin Immunol 2009;123:1361–70.
   PubMed Web of Science ®Google Scholar
• Cintorino M, Syrjanen S, Leoncini P, Bellizzi De ME, Petracca R, Pallini V, et al. Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix. Arch Gynecol Obstet 1988;241:235–47.
   PubMed Web of Science ®Google Scholar
• Lara C, Serra V, Marzo C, Valcuende F, Castells A, Bonilla-Musoles FM. Immunohistochemical localization of filaggrin in benign, premalignant and malignant cervical tissue. Arch Gynecol Obstet 1994;255:73–9.
   PubMed Web of Science ®Google Scholar
• McGlennen RC, Ostrow RS, Carson LF, Stanley MS, Faras AJ. Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues. Am J Obstet Gynecol 1991;165:696–705.
   PubMed Web of Science ®Google Scholar
• Kanitakis J, Ramirez-Bosca A, Reano A, Viac J, Roche P, Thivolet J. Filaggrin expression in normal and pathological skin. A marker of keratinocyte differentiation. Virchows Arch A Pathol Anat Histopathol 1988;412:375–82.
   PubMed Web of Science ®Google Scholar
• Viac J, Guerin-Reverchon I, Chignol MC, Chardonnet Y. Filaggrin expression in cutaneous and mucosal human papillomavirus induced lesions. Pathol Res Pract 1989;185:342–6.
   PubMed Web of Science ®Google Scholar
• Vigneswaran N, Peters KP, Hornstein OP, Haneke E. Comparison of cytokeratin, filaggrin and involucrin profiles in oral leukoplakias and squamous carcinomas. J Oral Pathol Med 1989;18:377–90.
   PubMed Web of Science ®Google Scholar
• Guerin-Reverchon I, Chardonnet Y, Viac J, Chouvet B, Chignol MC, Thivolet J. Human papillomavirus infection and filaggrin expression in paraffin-embedded biopsy specimens of extragenital Bowen's disease and genital bowenoid papulosis. J Cancer Res Clin Oncol 1990;116:295–300.
   PubMed Web of Science ®Google Scholar
• Campos AC, Murta EF, Michelin MA, Reis C. Evaluation of cytokines in endocervical secretion and vaginal pH from women with bacterial vaginosis or human papillomavirus. ISRN Obstet Gynecol 2012;2012:342075.
   PubMedGoogle Scholar
• Clarke MA, Rodriguez AC, Gage JC, Herrero R, Hildesheim A, Wacholder S, et al. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis 2012;12:33.
   PubMedGoogle Scholar
• Gillet E, Meys JF, Verstraelen H, Bosire C, De SP, Temmerman M, et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: A meta-analysis. BMC Infect Dis 2011;11:10.
   PubMed Web of Science ®Google Scholar
• Currie JM, Wright RC, Miller OG. The frequency of warts in atopic patients. Cutis 1971;8:243–5.
   Google Scholar
• Rubben A, Kalka K, Spelten B, Grussendorf-Conen EI. Clinical features and age distribution of patients with HPV 2/27/57-induced common warts. Arch Dermatol Res 1997; 289:337–40.
   PubMed Web of Science ®Google Scholar
• Rystedt I, Strannegard IL, Strannegard O. Recurrent viral infections in patients with past or present atopic dermatitis. Br J Dermatol 1986;114:575–82.
   PubMed Web of Science ®Google Scholar
• Cai SC, Chen H, Koh WP, Common JE, Van Bever HP, McLean WH, et al. Filaggrin mutations are associated with recurrent skin infection in Singaporean Chinese patients with atopic dermatitis. Br J Dermatol 2012;166:200–3.
   PubMed Web of Science ®Google Scholar
• Gao PS, Rafaels NM, Hand T, Murray T, Boguniewicz M, Hata T, et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol 2009;124:507–13, 513.
   PubMed Web of Science ®Google Scholar
• Montgomery SM, Ehlin AG, Sparen P, Bjorksten B, Ekbom A. Childhood indicators of susceptibility to subsequent cervical cancer. Br J Cancer 2002;87:989–93.
   PubMed Web of Science ®Google Scholar
• Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441–9.
   PubMed Web of Science ®Google Scholar
• Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–8.
   PubMed Web of Science ®Google Scholar
• Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry – history, content, quality and use. Dan Med Bull 1997;44:535–9.
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011;39:42–5.
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health 2011;39:26–9.
   PubMed Web of Science ®Google Scholar
• Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 2010;268:296–308.
   PubMed Web of Science ®Google Scholar
• Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: Baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003;10:377–86.
   PubMedGoogle Scholar
• Thuesen BH, Cerqueira C, Aadahl M, Ebstrup JF, Toft U, Thyssen JP, et al. Cohort profile: The Health2006 cohort, Research Centre for Prevention and Health. Int J Epidemiol 2014;43:568–75.
   PubMed Web of Science ®Google Scholar
• Alleman BW, Myking S, Ryckman KK, Myhre R, Feingold E, Feenstra B, et al. No observed association for mitochondrial SNPs with preterm delivery and related outcomes. Pediatr Res 2012;72:539–44.
   PubMed Web of Science ®Google Scholar
• Myking S, Boyd HA, Myhre R, Feenstra B, Jugessur A, Devold Pay AS, et al. X-chromosomal maternal and fetal SNPs and the risk of spontaneous preterm delivery in a Danish/Norwegian genome-wide association study. PLoS One 2013;8:e61781.
   PubMed Web of Science ®Google Scholar
• Osler M, Linneberg A, Glumer C, Jorgensen T. The cohorts at the Research Centre for Prevention and Health, formerly ‘The Glostrup Population Studies’. Int J Epidemiol 2011; 40:602–10.
   PubMed Web of Science ®Google Scholar
• Andersen AM, Olsen J. The Danish National Birth Cohort: Selected scientific contributions within perinatal epidemiology and future perspectives. Scand J Public Health 2011; 39:115–20.
   PubMed Web of Science ®Google Scholar
• Meldgaard M, Szecsi PB, Carlsen BC, Thyssen JP, Johansen JD, Menne T, et al. A novel multiplex analysis of filaggrin polymorphisms: A universally applicable method for genotyping. Clin Chim Acta 2012;413:1488–92.
   PubMed Web of Science ®Google Scholar
• Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study. BMJ 2002;325:572.
   PubMed Web of Science ®Google Scholar
• Kjaer SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence. J Natl Cancer Inst 2010;102:1478–88.
   PubMedGoogle Scholar
• Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: A systematic review and meta-analysis. Am J Epidemiol 2008;168:123–37.
   PubMed Web of Science ®Google Scholar
• Gosvig CF, Huusom LD, Andersen KK, Iftner A, Cederkvist L, Svare E, et al. Persistence and reappearance of high-risk human papillomavirus after conization. Gynecol Oncol 2013;131:661–6.
   PubMed Web of Science ®Google Scholar
• Badaracco G, Savarese A, Micheli A, Rizzo C, Paolini F, Carosi M, et al. Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer. Oncol Rep 2010; 23:1093–9.
   PubMed Web of Science ®Google Scholar
• Chen HC, Schiffman M, Lin CY, Pan MH, You SL, Chuang LC, et al. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 2011;103:1387–96.
   PubMedGoogle Scholar
• Skaaby T, Husemoen LL, Jorgensen T, Johansen JD, Menne T, Szecsi PB, et al. Associations of filaggrin gene loss-of-function variants and human papillomavirus-related cancer and pre-cancer in Danish adults. PLoS One 2014;9:e99437.
   PubMedGoogle Scholar
• Thyssen JP, Linneberg A, Johansen JD, Carlsen BC, Zachariae C, Meldgaard M, et al. Atopic diseases by filaggrin mutations and birth year. Allergy 2012;67:705–8.
   PubMed Web of Science ®Google Scholar
• Chen H, Common JE, Haines RL, Balakrishnan A, Brown SJ, Goh CS, et al. Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br J Dermatol 2011;165:106–14.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services PHSNIoH. SEER Program: Comparative staging guide for cancer. Cancer Statistics Branch, Division of Cancer Prevention and Control, National Cancer Institute 1993; NIH Publication No. 93-3640.
   Google Scholar